O
ISSUER//CIK 0001012140
ONYX PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 47.4 KBONYX PHARMACEUTICALS INCOct 3, 9:39 PM ET·0001181431-13-052530
- 429.1 KBONYX PHARMACEUTICALS INCOct 3, 9:30 PM ET·0001181431-13-052528
- 429.1 KBONYX PHARMACEUTICALS INCOct 3, 9:28 PM ET·0001181431-13-052525
- 422.4 KBONYX PHARMACEUTICALS INCOct 3, 9:24 PM ET·0001181431-13-052521
- 423.0 KBONYX PHARMACEUTICALS INCOct 3, 9:18 PM ET·0001181431-13-052519
- 421.0 KBONYX PHARMACEUTICALS INCOct 3, 9:10 PM ET·0001181431-13-052518
- 423.0 KBONYX PHARMACEUTICALS INCOct 3, 9:06 PM ET·0001181431-13-052514
- 414.6 KBONYX PHARMACEUTICALS INCOct 3, 9:03 PM ET·0001181431-13-052513
- 47.2 KBONYX PHARMACEUTICALS INCOct 3, 9:03 PM ET·0001181431-13-052512
- 422.7 KBONYX PHARMACEUTICALS INCOct 3, 9:01 PM ET·0001181431-13-052511
Insiders
10- Batlin Judy AVP, Org Learning, Dvlpmnt & HR
- Brege LauraEVP and Chief Business Officer
- CAGNONI PABLO JEVP, Global R&D and Tech Ops
- COLES N ANTHONYDirector, President & CEO
- Foster-Cheek Kaye ISVP, Global Human Resources
- FREEMAN SCOTT MVP, Clinical Research
- FUCHS HENRY JEVP & Chief Medical Officer
- Fust Matthew KChief Financial Officer
- GIOTTA GREGORY JVP & Chief Legal Counsel
- GODDARD PAULDirector
Tickers
No tickers on record
Addresses
business
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080
mailing
249 E. GRAND AVE.
SOUTH SAN FRANCISCO, CA, 94080